GBA Presents: THE GREEN MARKET

Aptose Clinical Data to be Presented at the 2021 ASH Annual Meeting
Aptose Biosciences, Inc.
November 4, 2021, 9:00 AM·3 min read
In this article:




HM43239 Data Accepted for Oral Presentation; Data for Luxeptinib and APTO-253 Accepted for Poster Presentation

SAN DIEGO and TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced that clinical data for HM43239, a myeloid kinome inhibitor in-licensed by Aptose (announced separately today – link) is being presented in an oral presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition, being held Saturday, December 11 – Monday, December 14, 2021 in Atlanta, GA and virtually. In addition, clinical data for luxeptinib, a dual lymphoid and myeloid inhibitor, and for APTO-253, a small molecule MYC oncogene repressor, have been accepted for poster presentation.
 
Damn this guy is forcing our hand---

IRA stock*****

B. Riley starts 'mispriced empire' Caesars with Buy, $191 target 07:52 CZR B. Riley analyst David Bain initiated coverage of Caesars Entertainment with a Buy rating and $191 price target. The analyst's base-case valuation combines $143 per share for the company's Las Vegas and regional brick-and-mortar casino businesses, $41 per share for the digital casino business, and $7 per share for its managed casino business. Further, after elimination of double-counting from divestments used for debt repayment, he estimates $35 of probable, additional per share value creation catalysts not included in the price target. Bain calls Caesars a "mispriced empire."
 

  • Chapek highlighted that Disney would be partnering with third parties on online betting. Reports in the summer started covering the prospect that ESPN would license its name to betting companies.
  • That's a potential boon for firms including Caesars Entertainment(NASDAQ:CZR)and DraftKings(NASDAQ:DKNG), not to mention Flutter Entertainment(OTCPK PDYPY), BetMGM(NYSE:MGM)and Fox (FOX,FOXA). And it's a "significant opportunity" for Disney, Chapek says. "It's all driven by the consumer, particularly the younger consumer ... and their desire to have gambling as part of their sports experience."
 
vanzandt said:
It's a Lithium play too.



Don't get mad, but I just planted 300 short in grannys garden at $69.65
Strictly a quick trade
More...


WAIT you Shorted SQM or APPS!!!

BE CAREFUL I AM PUTTING OUT THE WORD TO ROBIN HOOD TODAY:
DIGITAL TURBINE IS THE STOCK TO OWN APPS IS A BUY. Repeat*** Crawler software alert** stonedinvestor says buy APPS.
 
stonedinvestor said:
So after what we read on Aptose why make this move.....

In June APTO was $6<-------

I'm going to go out on a limb and call a bottom here--

Aug 17 it hit $2.50

This morning it's $2.50.

This may be THE VERY BOTTOM.... ($2 area)

1 yr DOWN 54%

1 Month UP 8% <------ OCT 25 marks the beginning of this move.---


GUMMY APTO
Aptose Biosciences Inc.
2.40
0.01(+0.42%)
4:00 PM 11/11/21
Pre-Market:$2.48+0.08(+3.33%)8:00 AM
More...


Get real-time quotes
APTOAPTOSE BIOSCIENCES INC COM NEW
$2.7469+0.3469 (+14.45%)
Bidx Size
$2.71x1,000
Askx Size
$2.75x6,500
 
You must log in or register to reply here.
Back
Top